Evidence map›Paper›PMID 35545412›Full record

Trial reportZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2022

Prevention of dexmedetomidine on postoperative delirium and early postoperative cognitive dysfunction in elderly patients undergoing hepatic lobectomy.

Yixun Tang, Yongsheng Wang, Gaoyin Kong, Yuan Zhao, Lai Wei, Jitong Liu

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Yixun TangCenter of Anesthesiology, Hunan Provincial People's Hospital/First Affiliated Hospital of Hunan Normal University, Changsha 410005. tangyixun1024@163.com.
Yongsheng WangCenter of Anesthesiology, Hunan Provincial People's Hospital/First Affiliated Hospital of Hunan Normal University, Changsha 410005.
Gaoyin KongCenter of Anesthesiology, Hunan Provincial People's Hospital/First Affiliated Hospital of Hunan Normal University, Changsha 410005.
Yuan ZhaoCenter of Anesthesiology, Hunan Provincial People's Hospital/First Affiliated Hospital of Hunan Normal University, Changsha 410005.
Lai WeiCenter of Anesthesiology, Hunan Provincial People's Hospital/First Affiliated Hospital of Hunan Normal University, Changsha 410005.
Jitong LiuCenter of Anesthesiology, Hunan Provincial People's Hospital/First Affiliated Hospital of Hunan Normal University, Changsha 410005. liujitong008@163.com.
Hunan Normal University · CNHunan University of Traditional Chinese Medicine · CN

Funding

the Natural Science Foundation of Hunan Province 2018JJ3296the Project of Changsha Science and Technology Bureau kq1901056
6 · The paper itself

Abstract

objectivesPostoperative delirium (POD) and postoperative cognitive dysfunction (POCD) are common operative neurocognitive disorders, which places a heavy burden on patients, families and society. Therefore, it is very important to search for preventive drugs. Previous studies have demonstrated that perioperative use of dexmedetomidine resulted in a decrease the incidence of POD and POCD. But the specific effect of dexmedetomidine on elderly patients undergoing hepatic lobectomy and its potential mechanism are not clear. This study aims to evaluate the efficacy of intraoperative use of dexmedetomidine on preventing POD and POCD in elderly patients undergoing hepatic lobectomy and the influence on the balance between proinflammation and anti-inflammation.

methodsThis trial was designed as a single-center, prospective, randomized, controlled study. One hundred and twenty hospitalized patients from January 2019 to December 2020, aged 60-80 years old with American Society of Anesthesiologists (ASA) II-III and scheduled for hepatic lobectomy, were randomly allocated into 3 groups (

resultsCompared with the C group, the incidences of bradycardia in the Dex1 group or the Dex2 group increased (both

conclusionsIntraoperative dexmedetomidine infusion can reduce the incidence of POCD and POD in elderly patients undergoing hepatic lobectomy, and the protective mechanism appears to involve the down-regulation of TNF-α and IL-1β and upregulation of IL-10 expression, which lead to rebalance between proinflammation and anti-inflammation.

Indexed as

Cognitive DysfunctionDeliriumDexmedetomidineHypotensionPostoperative Cognitive ComplicationsAgedAged, 80 and overBradycardiaHumansInterleukin-10Middle AgedPostoperative ComplicationsProspective StudiesTumor Necrosis Factor-alphaDexmedetomidineInterleukin-10Tumor Necrosis Factor-alphadexmedetomidineelderly patientshepatic lobectomypostoperative cognitive dysfunctionpostoperative delirium

Identifiers

PMID35545412
PMCPMC10930513
OpenAlexW4280515822

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.